XML 129 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Investments in equity investees (Tables)
12 Months Ended
Mar. 31, 2019
Investments in equity investees  
Investments in equity investees

 

 

 

 

 

 

 

 

 

    

Cost method

    

Equity method

    

Total

 

 

(in millions of RMB)

Balance as of April 1, 2017

 

35,404

 

84,964

 

120,368

Additions (i)

 

34,121

 

26,391

 

60,512

Share of results, other comprehensive income and other reserves (ii)

 

 —

 

(3,660)

 

(3,660)

Disposals

 

(3,051)

 

(474)

 

(3,525)

Transfers (iii)

 

(1,725)

 

(9,011)

 

(10,736)

Impairment loss (iv)

 

(1,753)

 

(18,153)

 

(19,906)

Foreign currency translation adjustments

 

(3,054)

 

(299)

 

(3,353)

Balance as of March 31, 2018

 

59,942

 

79,758

 

139,700

Transfer of cost method investments  (v)

 

(59,942)

 

 —

 

(59,942)

Balance as of April 1, 2018

 

 —

 

79,758

 

79,758

Additions (i)

 

 —

 

14,360

 

14,360

Share of results, other comprehensive income and other reserves (ii)

 

 —

 

1,905

 

1,905

Disposals

 

 —

 

(1,160)

 

(1,160)

Transfers (iii)

 

 —

 

(10,153)

 

(10,153)

Impairment loss (iv)

 

 —

 

(493)

 

(493)

Foreign currency translation adjustments

 

 —

 

237

 

237

Balance as of March 31, 2019

 

 —

 

84,454

 

84,454

 

(i)

Details of the significant additions of the investments in equity investees are set out in Note 4.

(ii)

Share of results, other comprehensive income and other reserves include the share of results of the equity investees, the gain or loss arising from the deemed disposal of the equity investees and the amortization of basis differences. The amount excludes the expenses relating to the share-based awards underlying the equity of the Company and Ant Financial granted to employees of certain equity investees (Note 8(d)).

(iii)

During the year ended March 31, 2018, transfers under the equity method were primarily related to the consolidation of Cainiao Network (Note 4(f)) and Intime (Note 4(g)) upon the acquisition of control by the Company.

During the year ended March 31, 2019, transfers under the equity method were primarily related to the consolidation of Alibaba Pictures (Note 4(b)).

(iv)

Impairment charges in connection with the equity method investments of RMB245 million, RMB18,153 million and RMB493 million were recorded in share of results of equity investees in the consolidated income statements for the years ended March 31, 2017, 2018 and 2019, respectively.

Impairment charges in connection with the cost method investments of RMB2,125 million and RMB1,753 million were recorded in interest and investment income, net in the consolidated income statements for the years ended March 31, 2017 and 2018, respectively.

Out of the impairment charges relating to the equity method investments for the year ended March 31, 2018, RMB18,116 million was related to the Company’s investment in Alibaba Pictures (Note 4(b)). The fair value measurements with respect to the impairments of other equity investees were individually insignificant and utilized a number of different unobservable inputs not subject to meaningful aggregation.

(v)Upon the adoption of ASU 2016-01, the Company no longer accounts for certain other equity investments in privately held companies over which the Company neither has control nor significant influence through investment in common stock or in-substance common stock using the cost method, and RMB59,942 million were reclassified into investment securities (Note 11) as of April 1, 2018.

Schedule of summarized financial information for all of the Company's equity method investments

 

 

 

 

 

 

 

 

 

    

Year ended March 31,

 

    

2017

    

2018

    

2019

 

 

(in millions of RMB)

Operating data:

 

 

 

 

 

 

Revenue

 

125,701

 

284,706

 

488,775

Cost of revenue

 

(109,790)

 

(242,068)

 

(405,074)

(Loss) Income from operations

 

(9,071)

 

(7,072)

 

3,840

Net (loss) income

 

(6,743)

 

195

 

2,923

 

 

 

 

 

 

 

 

As of March 31,

 

    

2018

    

2019

 

 

(in millions of RMB)

Balance sheet data:

 

 

 

 

Current assets

 

200,742

 

257,502

Non-current assets

 

184,310

 

222,484

Current liabilities

 

162,340

 

205,272

Non-current liabilities

 

26,107

 

34,191

Noncontrolling interests and mezzanine equity

 

16,586

 

10,151